Introduction
There are a number of well established risk factors for thrombotic vascular disease: cigarette smoking,1 hypercholesterolaemia, other dietary factors,2 and age and sex3 are amongst the best recognized. When risk indices are derived from known factors, however, their predictive value is more accurate for whole populations than for individuals. This suggests the possible existence of additional, important risk factors which are as yet undocumented.
The full pathophysiology of ischaemic vascular disease is still unresolved, although many studies describe the microscopic and gross lesions seen within the blood vessels. Recently, attention has shifted from abnormalities within the vessel wall to the study of thrombosis, blood constituents and their effects on blood flow, particularly in the field of cardiology. The red cell is poorly deformable and is able to obstruct the microcirculation, whilst platelet aggregation with the formation of platelet clumps can also decrease blood flow. The importance of plasma factors such as fibrinogen is also becoming recognized. In addition to its effect in the coagulation cascade, fibrinogen can increase blood viscosity, again slowing blood flow. Until the recent time, however, little attention has been paid to the white blood cell (WBC). It is the objective of this review to present current evidence for a new hypothesis of the mechanisms of tissue injury in ischaemia: one that involves the WBC. We know that atherosclerosis, vascular spasm, platelet thrombus and embolus formation all contribute to the development of arterial disease. There is also, however, increasing evidence to suggest that other key events may take place: i.e. obstruction of blood vessels in the microcirculation and tissue injury by the polymorphonuclear leucocytes (neutrophils, PMNs). myocardial infarction has been well documented. 4 4 In this situation, a migrating population of inflammatory cells reaches the margin of the infarct and progresses towards the centre; thus, necrosis and the repair process progress in the same direction. However, recent evidence suggests a broader and earlier role for neutrophils in the acute injury process, and these cells may be a mediator of cell damage during ischaemia. Let us first examine the possible mechanisms whereby the WBC can effect cell damage.
How may the white blood cell contribute to ischaemic disease?
There are several possible explanations as to how the white blood cell may contribute to thrombosis. The white cell count (WCC) appears to be a risk factor for arterial disease in a number of epidemiological studies. 5-7 One explanation for this is that the WCC may serve as a marker for one or more disease processes which have led to the vascular injury. For example, the marginal pool of PMNs can be rapidly mobilized into the circulating pool by stimuli such as exercise and adrenaline,8 and it may be stimuli such as these which produce the damage to the vasculature, the elevated WCC occurring as a byproduct. Alternatively, WBCs may play a pathogenic role in thrombosis, and evidence is accumulating to suggest that this is so particularly for the PMN. PMNs are the predominant members of the granulocyte class of WBCs which make up approximately 60% of the total WCC in humans.
The adhesive, secretory, locomotor and invasive properties of neutrophils have been known for over a hundred years. They have a scavenging role and help to clear damaged or dying tissue, bacterial pathogens and small foreign bodies. They can also, however, effect vascular damage by (1) the release of noxious chemicals, (2) physical obstruction and (3) interactions with other constituents of the blood.
Chemical effects of WBCs
If a PMN becomes trapped in the microvasculature it can deliver a variety of insults to the blood vessel lining ( Table 1 ). The chemical substances released from the WBC would normally be utilized in the protection of the Table 1 Chemicals active in blood coagulation and thrombosis released from PMNs organism against microbial invaders, but such defence mechanisms can also be prothrombotic. One mechanism by which neutrophils may promote tissue damage is through the release of lysosomal enzymes into the microenvironment. Neutrophil elastase, a serine protease, is one of the most potent of the lysosomal enzymes. Its substrates include important matrix molecules such as fibrinogen, fibronectin, collagen and elastin. Neutrophil elastase is known to be implicated in endothelial damage in vitro; its effects include digestion of basement membrane and increased endothelial adhesiveness, permeability and oedema.9 Increased levels have been detected in patients with myocardial infarction (MI)9 and it can escape inhibition by al-antitrypsin in the presence of free radicals which are also released by WBCs. A number of other white cell release products apart from elastase have been implicated in causing vascular damage or have been found to be elevated in arterial disease, suggesting white cell activation in these diseases (granulocyte alkaline phosphatase levels, for example, are increased following Mlll, and the histamine content of leucocytes is increased in peripheral arterial disease (PAD) 12) . Neutrophil activation also results in the release of leukotrienes and other 5-lipoxygenase metabolites of arachidonic acid. Leukotriene B4 (LTB4) is a very potent chemoattractant, causing neutrophils to accumulate in the area of ischaemic injury. 13 LTB4 also initiates neutrophil aggregation and degranulation.
Furthermore, it can also affect the blood vessels directly by promoting endothelial permeability and plasma leakage. 13 Mehta et al.9 have shown increased LTB4 production by the PMNs of patients with MI and unstable angina. Small amounts of LTD4, C4 and E4 are also released, and these can increase vascular resistance and reduce blood flow in the microcirculation. 14 In the course of phagocytosis and bacterial killing, neutrophils consume large quantities of oxygen which may be transformed into toxic oxygen metabolites, some of which are free radicals (FRs). Most molecules have their electron orbits filled with paired electrons spinning in opposite directions. If an atom or molecule exists with one or more unpaired electrons in the outermost shell it can be regarded as a FR. FRs attempt to donate or accept electrons from other compounds in an effort to increase their stability, leading to the potential for chain reactions, the generation of energy and the formation of other radical species. During these reactions FRs are capable of producing conformational changes in cell components that can lead to cell death or at least severe cellular dysfunction. At the present time the most important FRs are considered to be those derived from oxygen. Reduction of 02 to water produces intermediary products which are much more reactive than 02. Two of these are FRs: superoxide (02w) and hydroxyl radical (ohm).
OH. is a powerful oxidizing agent, and although O2,-is probably less reactive it may be converted to the potent singlet oxygen by reacting with hydrogen peroxide. 15 Free radicals interact with proteins, nucleic acids and lipids. The oxidation of protein in cell membranes, particularly the sulphydryl groups on the proteins of ion channels and pumps, can also have serious effects on membrane function.
Additionally, FR-induced damage of DNA will affect cell function by interfering with protein synthesis. 15 Damage to cell membrane lipidlipid peroxidation -will also affect cell membrane function. Thus, FR damage to the blood vessel endothelial cell can occur. Such direct damage will increase the likelihood of thrombosis occurring over the damaged area (Figure 1 ). This prothrombotic effect is enhanced by the alteration in the production of endothelial-derived antithrombotic substances by FRs and FR products. Endothelial production of prostacyclin (PG12) is decreased by lipid peroxides PG12 is a potent antiplatelet agent and vasodilator. Furthermore, it inhibits PMN aggregation 17 and decreases PMN adhesion to both intact and damaged endothelial cells. 18 A decrease in its production by lipid peroxides may lead to further WBC accumulation. Thromboxane A2 (TXA2) has an opposite effect to PG12, being a potent platelet aggregant and vasoconstrictor which has its production enhanced by the generation of FRs. This is brought about by the interaction of FRs with the arachidonic acid (AA) cascade. FRs are produced during the metabolism of PGG2 to PGH2, and OH. in turn enhances the action of the cyclo-oxygenase enzyme, the net effect of which is to activate the AA pathway and enhance production of TXA2 and the 2 series PGs ( Figure  2 ). With the inhibition of PG12 production by lipid peroxides the net effect is a selective enhancement of TXA2 production.15 Lipid peroxides also increase the cholesterol-donating ability of LDL and inhibit the cholesterolaccepting capacity of HDL,19 thereby promoting cholesterol accumulation in blood vessel cells and augmenting the development of atherosclerosis. Lipid peroxides may further contribute to thrombosis by increasing the generation of thrombin via inhibition of antithrombin III.2° FRs can also directly affect endothelial function: O2,enhances the breakdown of endothelium-derived relaxant factor.21 This endogenous vasodilator controls vascular tone, and its increased destruction may lead to an increase in tone which may be vitally important in situations where blood flow is already compromised.
It is likely that the most important source of FRs are the PMNs but it is important to note that FRs can also be produced via alternative mechanisms and these may also be important in the development of metals, can catalyse FR formation. Indeed, the superoxide ion cannot effect oxidative damage in the absence of iron, and experimental work has shown that chelation of iron will prevent tissue injury following ischaemia in animal models. 28
Studies in man show that the levels of protective enzymes are depleted in atherosclerotic vascular disease affecting the coronary and peripheral vessels,29,30 and that excess lipid peroxidation can be detected both after acute ischaemia 31 and in chronic vascular disease. 32 The xanthine oxidase inhibitor, allopurinol, appears to attenuate changes in blood viscosity in patients with PAD. 33 Furthermore, another measure of FR activity, the oxidation of adrenaline to adrenochrome, has been used to detect increased activity in acute stroke patients. 34 FRs are most likely to effect vascular damage during reperfusion of an ischaemic areals: catecholamine and AA metabolites are increased, the oxygen supply is returned, activated PMNs accumulate and xanthine oxidase shows increased activity. Acting together, all these factors produce bursts of FRs which could overwhelm the body's homeostatic mechanisms against FR attack. In order to test this hypothesis, however, better methods for detecting direct FR generation must be developed, and until this time the potential importance of FR-modulating therapies in vascular disease cannot be accurately assessed.
Physical effects of WBCs
Neutrophils are large cells with a diameter of about 8 microns which must deform substantially in order to pass through the small capillaries with typical diameters of between 5-6 microns. Thus, the rheological properties of the WBC constitute a significant determinant of blood flow in the microcirculation. A number of the rheological properties of PMNs have been described in recent years, most strikingly the fact that they are about 2000 times stiffer than the erythrocyte.35 After activation, PMNs start to project pseudopods, and their cytoplasm increases in stiffness further. 35 Even in normal circumstances the entry of WBCs into capillaries can take several seconds.36 This gives rise to intermittent capillary plugging in atherosclerosis, in which there is already a low perfusion state. The WBC can become entrapped in the microcirculation, causing prolonged disturbances of flow. 22 Poorly deformable cells will increase this tendency to block narrow vessels. Hard WBCs have been detected in patients with acute cerebral infarction 37 and chronic cerebral vascular disease, 38 as well as in patients with peripheral vascular disease affecting the legs.39 Hard cells have also been detected in patients following MI.40 Adhesion of the WBC to the endothelium and to other cells including other WBCs (aggregation) is another important property of the neutrophil which may have implications with respect to their effect on the microcirculation. The strength of PMN adhesion in combination with the pressure gradient in the capillary will determine whether the cell will become trapped in the vessel. Fisher et al . 41 have described increased PMN aggregation in whole blood from patients with MI, and increased clumping and pseudopod formation has been described in separated WBCs taken from patients with unstable angina.42 Thus, the activation with simultaneous accumulation of granulocytes in the microvasculature may lead to vascular injury and furthei WBC activation. This manifests after reperfusion by the failure of blood flow to return uniformly to the ischaemic area, the so-called 'no reflow' phenomenon, which is probably due to the plugging by neutrophils of the microvascular bed. It is perpetuated by the WBC release reaction and further activation leading to an increase in vascular resistance, vessel wall oedema and injury. 25
Interaction of neutrophils with other blood constituents Through the interaction of WBCs with other blood constituents the initial prothrombotic effect described above can be magnified (Figure 2 ). WBCs can interact with red blood cells (RBCs). FRs themselves directly damage RBCs causing them to leak ADP which in turn promotes platelet aggregation. Lipid peroxides produced by FR activity decrease RBC deformability,43 and treatment with a. xanthine oxidase inhibitor in patients with PAD increases whole blood filtrability and decreases whole blood viscosity.33
In turn, RBC concentration affects the positioning of PMN in the circulation. Without margination and adhesion, invasion of the tissue by the PMN is not possible, thus, the margination of the neutrophil is of fundamental importance for neutrophil function. Neutrophils do not actively move across the blood stream however, and margination is initiated by erythrocytes in postcapillary vessels. This margination can be affected by poorly deformable red cells and red cell number.4a
In the same way, PMNs can interact with platelets to produce platelet activation which can play an important role in thrombosis. Neutrophilderived FRs increase platelet aggregation,2o,as and leukotriene-stimulated TXA2 release from the PMN will also potentiate platelet aggregation.46 It is of interest that neutrophil depletion in animals protects the ischaemic myocardium against platelet deposition. 47 WBCs themselves can also be stimulated by platelet-release products such as adrenaline and serotonin which increase PMN adhesion. 48 Furthermore, a platelet-derived lipoxygenase product stimulates neutrophil LTB4 and 5-HETE formation in
PMNs.49
It is important to remember, however, that although this review deals with the prothrombotic effects of the PMN, the leucocyte can also inhibit thrombosis. The PMNs proteases have a well documented effect on the lysis of fibrin 50 and can also influence the activity of blood clotting factors. 51 More recently the mechanisms of the WBC's antithrombotic effect have been extended by Buchanan et al. 52 PMNs, like endothelial cells, synthesize both 13-hydroxyoctadecadienoic acid (13-HODE) and PG12. Both 13-HODE, a lipoxygenase-derived metabolite of linoleic acid, and PG'2 decrease platelet aggregation. It is thought that the WBCs seen to accumulate over the surface of a thrombus may further inhibit thrombus growth by platelet inhibition. Thus, although the WBC may be instrumental in initiating thrombosis, in some situations it may also play a part in limiting its extent (Table 1) .
Epidemiological considerations
In many epidemiological studies the WCC has been shown to be a powerful and consistent predictor of cardiovascular events. 5-7 Many studies have shown that an increased WCC within the 'normal range' following MI is predictive of further coronary events. In the Paris I study, 2026 patients with MI were investigated by Lowe et al.' They found a positive correlation between WCC and sudden death and reinfarction. Haines et a1.6 reviewed 272 patients with MI and found that the 68 who died within one year had significantly higher WCCs. It might be suggested that the larger the initial area of tissue damage the brisker the acute-phase response would be following MI, including an increase in WCC.
Thus, the increase in WCC seen in these studies could merely reflect the severity of the first infarct. However, 464 patients with their first MI who had had a WCC measured in the preceding two years were studied by Friedman et al. 53 These patients were compared with two control groups, one of which was matched for race, gender and age and the other additionally matched for the conventional risk factors. The WCC was a strong predictor of infarction with a predictive value similar to that of a single determination of blood pressure or a serum cholesterol measurement.
The WCC is increased by cigarette smoking, 54 as in the study by Friedman et al. 55 where cigarette smoking correlated positively with the WCC. Only two-thirds, however, of the excess risk of the high-count individuals was explicable on the basis of cigarette smoking. In support of the WCC as an independent risk factor, Zalokar et a1.55 carried out a prospective study where over 7000 males were followed for an average of 6.5 years. Among the men who smoked the WCC correlated strongly with the risk of MI. Smokers with a WCC greater than 9 x 109/1 had four times the incidence of MI compared to smokers with WCC below 6 x 109/1.
The survivors of the Japanese atomic-bomb blasts were investigated by Prentice et al. 56 This group of investigators were able to correlate total WCC and differential counts with the risk of coronary artery disease (CAD). They found that the total WCC had a positive and significant correlation with CAD, and that this was independent of cholesterol, blood pressure, sex or smoking. Fortuitously, they had measured the differential WCC. Their results suggest that the most important cell with reference to vascular disease is the PMN. Monocyte and eosinophil counts were also predictive, but lymphocyte counts were not.
Studies do not only correlate an elevated WCC with ischaemic events, but also show that a decreased count is associated with decreased risk. In the 'MRFIT'
(Multiple Risk Factor Intervention Trial) studiess7 there was a strong correlation between the WCC and CAD prevalence, risk of nonfatal MI and risk of sudden cardiac death. This was independent of other risk factors and, moreover, if the WCC fell during the time of the study then so did the risk for CAD. A decrease of 1 x 109 WBC/I was associated with a 14% fall in risk of cardiac death, which is inexplicable on the basis of other risk factors. The suggestion that the lower the count the lower the cardiovascular risk is supported by studies of neutropenic states. Laboratory work investigating animals depleted of neutrophils by a neutrophil antiserum showed that they experienced smaller MIs58 and fewer arrythmias.59 This work is complemented by an epidemiological study of the Yemenite Jews, 60 who frequently have a benign constitutional neutropaenia and have been shown to experience vascular events only infrequently. It is likely that this correlation between WCC and vascular disease is meaningful. Two smaller studies have linked WCC both to the extent of atherosclerosis as determined by coronary arteriography61 and ventricular arrythmias. 62
The risks associated with an increased WCC are not limited to the coronary vessels. The total WCC also correlates with the risk of rethrombosis following peripheral vascular grafting63 and with the risk of thrombotic stroke.64,65 There is therefore convincing evidence to show that an elevation of the leucocyte count in the peripheral blood is associated with an increased risk of generalized vascular disease.
Potential for therapy
Flow in the microcirculation can be inhibited through rheological and functional changes in the WBC. Thus, a treatment which inhibits WBC activation in the early stages of ischaemia may have beneficial effects, even though the normal WBC response may be essential for later stages of healing. Some conventional antithrombotic drugs can have 'anti-white cell effects'. We already know that heparin inhibits both white cell degranulation and aggregation,66 and warfarin has FR scavenging properties. Cyclooxygenase inhibitors such as aspirin decrease the production of FRs by the PMN 67 and may inhibit neutrophil aggregation. 68 Prostacyclin and its analogues are also used in the treatment of vascular disease69 and their anti-white cell effects are now being well described. 17,18 Inhibition of both the 5-lipoxygenase and cyclo-oxygenase metabolism of AA leads to decreased production of both LTB4 and TXA2. Such agents limit myocardial neutrophil accumulation and infarct size . 70 Although this work is interesting it should be noted that it has so far been limited to animal models.
Other pharmaceutical agents used in the field of cardiovascular medicine include the ACE inhibitors. Captopril -used to treat heart failure, a disease in which FR pathology occurs71 -has a sulphydryl group within its molecule and is a potent scavenger of FRs,'2 which may explain some of its beneficial effects in other vascular situations. 73 Calcium channel blockers may also, by the nature of their mechanism, decrease WBC activity. Conventional antioxidants such as Vitamin E and Vitamin C both have antiplatelet and FR-scavenging effects. 74 Work investigating the potential beneficial effects of FR scavengers in ischaemia/reperfusion is well described in animals, although not yet in humans.
Recombinant human SOD is now available, and the problems with anaphylaxis using this compound may now be avoided. Study in this area of research will soon be published. Whatever form of pharmacological intervention is being designed it must be limited in the extent of its effects and not interfere with the vital physiological functions of the PMN such as healing. This will, no doubt, be a challenging task for the future.
Conclusion
In addition to its traditional role in combating infection and scavenging dead tissue, the white cell may have a key role in mediating vascular damage. There is evidence that the WCC may be an independent predictor of risk for vascular disease. Knowledge of WBC behaviour supports a pathophysiological role for the cells so that this epidemiological evidence is credible. Important areas for future study are the activation and degranulation sequence of the white cell in the ischaemic tissue; the extent and form of any injury caused by FRs and lysosomal enzymes; and the nature and source of chemotatic substances. Further study of WBC function in vascular disease is required before the WBC can finally be added to the ever expanding list of cardiovascular risk factors. Further work is also needed to define an appropriate strategy whereby neutrophil function can be modified while still maintaining necessary tissue repair functions.
